WHEATON® Primary Packaging Solutions manufactured by SciLabware
WHEATON> primary packaging solutions manufactured by SciLabware SciLabware Limited, a company of DWK Life Sciences, is one of the world’s leading manufacturers of high quality primary packaging solutions to the diagnostic and pharmaceutical industries across the globe.
SciLabware Limited, a company of DWK Life Sciences, is one of the world’s leading manufacturers of high quality primary packaging solutions to the diagnostic and pharmaceutical industries across the globe.
Utilising SciLabware’s extensive manufacturing and development capabilities, our flexible product offering includes bespoke custom solutions coupled with premium services, to suit your primary packaging requirements. From barcoding and tare weighing to depyrogenation to custom packaging, our goal is to provide the right solution to your daily packaging challenges.
We provide our customers quality solutions, meeting their highest demands with our expertise and broad product portfolio, including ampoules, dropper pipettes and assemblies, glass and plastic bottles and a comprehensive range of vials and closure systems.
Our flexible approach to each and every project means our customers benefit from a single source supply partner with exceptional customer service.
Visit us on stand G102 at Pharmapack 2019 in Paris to find out more.
For further information visit https://www.scilabware.com/en/packaging or email your questions to: enquiries@scilabware.com with the subject line Pharma Tech Europe.
Contact Details:
Company name: SciLabware Ltd
Website: www.scilabware.com
E-mail: enquiries@scilabware.com
Stand/Booth number: G102
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
